Answers are grounded in this paper and cite their sources.
Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease characterized by immune dysregulation. Both hypoxia and lactylation have been implicated in immunity and inflammation, but their underlying mechanisms in RA remain unclear. This study aimed to identify candidate biomarkers associated with hypoxia- and lactylation-related features in rheumatoid arthritis (RA) through bioinformatic analyses and assessment of tissue protein expression. Differentially expressed genes (DEGs) were identified in blood and synovial tissue samples. Weighted gene co-expression network analysis (WGCNA) was used to identify module genes associated with hypoxia and lactylation. Candidate genes (CGs) were identified from the intersection of DEGs and module genes. Machine learning algorithms and expression analysis were applied to screen candidate biomarkers. Gene set enrichment analysis (GSEA) was performed to explore pathways related to the candidate biomarkers. Single-cell RNA sequencing (scRNA-seq) was used to explore the expression of the candidate biomarkers across different cell populations in one peripheral-blood sample from a patient with RA. Finally, immunohistochemical staining was performed on synovial tissue to assess the protein expression levels of the identified candidate biomarkers. TIMM8B and ABLIM1 were identified as candidate biomarkers that shared pathways related to cell homeostasis and immunity, including oxidative phosphorylation and the Toll-like receptor signaling pathway. In this RA peripheral-blood sample, ABLIM1 was mainly detected in CD8 + T cells, whereas TIMM8B showed relatively high expression in plasma cells. Immunohistochemical results showed significantly increased TIMM8B protein in RA synovial tissue, and ABLIM1 protein also showed a relatively strong positive signal. This study identified candidate biomarkers associated with hypoxia- and lactylation-related transcriptional features in RA and suggested that they might be associated with RA-related immune dysregulation. These findings provide new clues for understanding RA-related molecular and immune features and a basis for subsequent mechanistic research and candidate-target evaluation.
No takes yet. Share an insight, caveat, or question.
Duan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: